Configuration Control vs. Document Control – Managing Design Changes Across Modern Quality Systems
Learn why Configuration Architecture — not Document Control — defines the modern Quality System, and how treating relationships as first-class objects strengthens traceability, change control, and inspection readiness.
Instructor
José Mora
Medical Device Quality Systems & Configuration Management Consultant
What You'll Learn
About the event
About this event
This is not a webinar about document control. It is a webinar about Configuration Architecture and the architecture of a modern Quality System. Traditional systems often treat requirements, risks, risk controls, design outputs, software, hardware, manufacturing processes, suppliers, verification, validation, regulatory evidence, training, equipment, tools, locations, and documents as separate categories. The real product, however, is defined by the relationships among those elements.
Those relationships must be treated as first-class objects. They show which requirement is implemented by which design output, which risk is addressed by which control, which software version operates with which hardware configuration, which supplier provides which component, which process produces which output, and which verification or validation evidence supports an approved configuration state. A document may present those relationships, but the document is not the architecture. A traceability matrix may display relationships, but traceability is evidence of relationship integrity; it is not the architecture itself.
The webinar challenges several common assumptions: that Quality Systems are primarily document systems, that Document Control equals Configuration Control, that traceability is the objective, that more documents improve compliance, that Configuration Management is only for aerospace, that PLM is only an engineering tool, that documents define the product, and that digitizing documents solves the information problem.
The distinction is fundamental: Configuration Control is an activity. Configuration Architecture is the structure that makes control possible. Configuration Architecture establishes the objects, relationships, references, states, and evidence required to understand what a product is, how it is made, how it is verified and validated, how it is supplied, and how it remains compliant throughout its life cycle.
Under this model, documents are not merely outputs. They are user interfaces into the approved configuration — Manufacturing sees Work Instructions, Quality sees procedures and quality records, Regulatory sees regulatory evidence and design history information, Production sees production records, Purchasing sees supplier and purchasing information, Service sees service information, and AI consumes structured objects, relationships, states, and evidence. These are different views into the same approved configuration — not independent bodies of truth.
The practical Lean Documents principle is direct: information should never travel. References travel. Information remains in the Single Source of Truth. Every copied piece of information creates another synchronization problem. Every disconnected relationship creates uncertainty about impact, status, and evidence.
When a change is made, the question is not merely "Which documents must be revised?" The more important question is "Which configuration objects and relationships are affected?" That shift improves change impact assessment, reduces document synchronization effort, strengthens Design Controls, and makes regulatory evidence more coherent.
A Configuration-First Quality System provides a common enabling architecture for Design Controls, Risk Management, Verification, Validation, Supplier Control, Manufacturing, PLM, MES, ERP, Digital Thread, Digital Twin, Artificial Intelligence, and Inspection Readiness. These depend on the same foundation: reliable approved configuration information and intact relationships. Configuration integrity is the objective. Traceability is one of the outcomes.
KEY TAKEAWAY: A modern Quality System should control the configuration first and generate the documents second. The product exists independently of its documentation. Configuration defines the product. Documents are generated views and user interfaces into the approved configuration. Traceability demonstrates that relationships are intact, but it is not a substitute for the architecture that creates and maintains those relationships.
Code: MD1383
Curriculum
Requirements
- Quality Assurance, Regulatory Affairs, Design/Development, Systems/Software, and Manufacturing Engineering professionals
- Applicable to Configuration/Change Management, Document/Records Management, Risk Management, Verification/Validation, and Supplier Quality roles
- Relevant to PLM, MES, ERP, and Digital Transformation teams, and executive leaders responsible for Quality System effectiveness
Who Should Attend
The primary audience includes managers, engineers, auditors, consultants, and technical professionals who need to understand how configuration decisions affect product quality, regulatory evidence, manufacturing execution, and change control. The webinar is particularly relevant to professionals who manage large document sets, investigate inconsistencies, conduct change assessments, support inspections, or evaluate digital Quality System investments. It is also designed for leaders who need a coherent foundation for PLM, Digital Thread, Digital Twin, connected manufacturing, Model-Based Engineering, and AI-enabled Quality Systems — including Quality Assurance and Quality Engineering, Regulatory Affairs, Design and Development Engineering, Systems and Software Engineering, Manufacturing and Process Engineering, Configuration and Change Management, Document and Records Management, Risk Management, Verification and Validation, Supplier Quality, Operations and Technical Training, PLM/MES/ERP and Digital Transformation teams, and executive leaders responsible for Quality System effectiveness.
Areas Covered
Meet Your Instructor

José Mora
Medical Device Quality Systems & Configuration Management Consultant
José Ignacio Mora is a Principal Consultant specializing in Manufacturing Engineering, Quality Systems, Design Controls, and Configuration Management within the medical device industry. For more than three decades he has worked across product development, manufacturing, quality systems, process validation, supplier management, technology transfer, and regulatory compliance. His experience includes leadership positions at Boston Scientific, Stryker Orthopedics, Cordis Corporation, and multiple start-up medical device organizations. José is the creator of the Lean Documents and Lean Configuration methodology, a relationship-centric approach to managing quality system information. His work focuses on improving traceability, reducing information fragmentation, strengthening inspection readiness, and creating more effective connections between requirements, risks, verification activities, validation activities, and released product configurations. Drawing from practical experience in design controls, process validation, manufacturing systems, quality systems remediation, and organizational transformation, José provides a unique perspective on how organizations can achieve compliance while simultaneously reducing complexity and improving operational effectiveness.
Event Details
Format
Recorded Webinar
Duration
1.5 hours
Certificate
Included
Access
Lifetime
Related Events
Digital Quality Metrics and AI/ML Analytics: Building a Continuous-Improvement Framework that Aligns with Regulatory Expectations
Learn how AI/ML and real-time digital quality metrics build a continuous-improvement framework aligned with FDA regulatory expectations, 21 CFR Part 11, and GAMP®5.

AI in GMP: What the FDA Is Already Expecting - Before You Ask
FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.

HPLC Analytical Method Development and Validation
Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.